ProfileGDS4718 / 1570033_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 20% 28% 18% 29% 22% 23% 24% 28% 21% 20% 22% 19% 26% 19% 25% 21% 23% 22% 27% 26% 30% 24% 17% 24% 19% 17% 22% 16% 23% 29% 25% 20% 22% 20% 24% 20% 18% 23% 24% 25% 23% 24% 20% 21% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1731620
GSM549102patient 115, normal, homogenized [OPG study]4.4771628
GSM549104patient 119, normal, homogenized [OPG study]4.0399718
GSM549108patient 138, normal, homogenized [OPG study]4.53129
GSM549119patient 077, normal, homogenized [OPG study]4.2213922
GSM549133patient 032, cancer, homogenized [OPG study]4.2096623
GSM549139patient 042, cancer, homogenized [OPG study]4.2924124
GSM549099patient 107, normal, homogenized [OPG study]4.4701528
GSM549109patient 139, normal, homogenized [OPG study]4.2096921
GSM549110patient 046, normal, homogenized [OPG study]4.1587620
GSM549114patient 063, normal, homogenized [OPG study]4.1789322
GSM549122patient 082, normal, homogenized [OPG study]4.1277519
GSM549134patient 033, cancer, homogenized [OPG study]4.3841726
GSM549136patient 036, cancer, homogenized [OPG study]4.0520519
GSM549140patient 044, cancer, homogenized [OPG study]4.2947425
GSM549111patient 047, normal, homogenized [OPG study]4.1742421
GSM549113patient 057, normal, homogenized [OPG study]4.2147323
GSM549132patient 031, cancer, homogenized [OPG study]4.2083922
GSM549137patient 038, cancer, homogenized [OPG study]4.414127
GSM549142patient 047, cancer, homogenized [OPG study]4.4755726
GSM549100patient 110, normal, homogenized [OPG study]4.5428330
GSM549107patient 135, normal, homogenized [OPG study]4.2771624
GSM549115patient 068, normal, homogenized [OPG study]3.9902317
GSM549116patient 072, normal, homogenized [OPG study]4.2683924
GSM549120patient 078, normal, homogenized [OPG study]4.107919
GSM549131patient 030, cancer, homogenized [OPG study]4.0061817
GSM549118patient 074, normal, homogenized [OPG study]4.2199822
GSM549129patient 027, cancer, homogenized [OPG study]4.0136616
GSM549123patient 088, normal, homogenized [OPG study]4.2648723
GSM549124patient 006, cancer, homogenized [OPG study]4.5587129
GSM549126patient 015, cancer, homogenized [OPG study]4.31925
GSM549128patient 025, cancer, homogenized [OPG study]4.1199720
GSM549103patient 117, normal, homogenized [OPG study]4.2589122
GSM549117patient 073, normal, homogenized [OPG study]4.1277520
GSM549138patient 041, cancer, homogenized [OPG study]4.2611624
GSM549141patient 045, cancer, homogenized [OPG study]4.1039120
GSM549130patient 028, cancer, homogenized [OPG study]4.1014918
GSM549101patient 111, normal, homogenized [OPG study]4.2652823
GSM549105patient 128, normal, homogenized [OPG study]4.3322424
GSM549106patient 134, normal, homogenized [OPG study]4.2719125
GSM549112patient 048, normal, homogenized [OPG study]4.2562323
GSM549125patient 011, cancer, homogenized [OPG study]4.3240824
GSM549127patient 024, cancer, homogenized [OPG study]4.1228920
GSM549135patient 035, cancer, homogenized [OPG study]4.1292921